Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06623981 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Apr 30, 2027 to Dec 15, 2026 Completion date: Apr 30, 2027 to Mar 15, 2027 · Eligibility criteria expanded, about 15 wordsv4 Show 2 more changesShow less
    • Completion date: Apr 30, 2027 to Mar 15, 2027
    • Eligibility criteria expanded, about 15 words

    See this version in full on ClinicalTrials.gov ↗

  2. Eligibility criteria expanded, about 9 words Secondary endpoints: details revised at 1 of 15 entries · Site contact updated · Study description shortened, about 2 wordsv3 Show 3 more changesShow less
    • Secondary endpoints: details revised at 1 of 15 entries
    • Site contact updated
    • Study description shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 16, 2024 to Oct 15, 2024 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Oct 16, 2024 to Oct 15, 2024
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to test the effectiveness and implementation of delivering Enhanced Brief Interpersonal Psychotherapy (IPT-B), an evidence-based maternal depression treatment, to mothers of children under the age of 18 in an urban pediatric asthma clinic. Researchers will compare Enhanced IPT-B and supplemented usual care (brief care coordination). The main questions the trial aims to answer are: 1. Does Enhanced IPT-B decrease maternal depressive symptoms? 2. Does Enhanced IPT-B improve child asthma management and health outcomes (exacerbations, symptoms, control)? 3. What are the preliminary implementation outcomes of delivering Enhanced IPT-B in an urban pediatric asthma clinic?
Trial Details
NCT Number NCT06623981
Lead Sponsor Children's National Research Institute
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD)
Conditions Asthma in Children, Depression
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov